4/5/2013

The FDA has cleared CryoLife to market its Hemodialysis Reliable Outflow, or HeRO, system. The next-generation device, set to be released in the fourth quarter, provides long-term AV access for central venous stenosis patients undergoing hemodialysis and improves on the original version with an adaptor for integration with other dialysis access grafts.

Full Story:
RTT News

Related Summaries